ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.430,05
1,42%
S&P 500
5.186,01
0,10%
Dow Jones
38.865,88
0,04%
Euro vs US Dollar
1,07603
-0,06%
Bitcoin
63.397,87
0,37%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Selecta Biosciences Inc (SELB)

  7. Selecta Biosciences Inc (SELB) News

SELB Selecta Biosciences Inc

0,8812
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Selecta Biosciences Inc SELB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 0,8812 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,8812
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
26.4.202415:09EDGAR2Form DEF 14A - Other definitive proxy statements
26.4.202413:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22.4.202412:25EDGAR2Form 8-K - Current report
19.4.202422:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
11.4.202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.4.202403:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.4.202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.4.202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.4.202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.4.202422:29EDGAR2Form SC 13D/A - General statement of acquisition of..
10.4.202422:25EDGAR2Form SC 13D/A - General statement of acquisition of..
10.4.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.4.202413:00EDGAR2Form 8-K - Current report
01.4.202422:32EDGAR2Form 8-K - Current report
28.3.202422:00EDGAR2Form 8-K - Current report
14.3.202412:55EDGAR2Form 8-K - Current report
07.3.202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202413:06EDGAR2Form 8-K - Current report
05.3.202413:05EDGAR2Form 8-K - Current report
14.2.202423:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14.2.202422:42EDGAR2Form DEF 14A - Other definitive proxy statements
14.2.202418:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31.1.202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23.1.202422:05EDGAR2Form 8-K/A - Current report: [Amend]
19.1.202422:12EDGAR2Form 8-K - Current report
12.1.202422:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
08.1.202414:45EDGAR2Form 8-K - Current report
08.1.202413:10GLOBECartesian Therapeutics Highlights Progress and 2024..
08.1.202413:00GLOBECartesian Therapeutics Announces Positive Long-Term..
04.1.202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.12.202322:28EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
04.12.202322:39EDGAR2Form D/A - Notice of Exempt Offering of Securities: [Amend]
01.12.202314:31EDGAR2Form S-3/A - Registration statement under Securities Act of..
27.11.202322:18EDGAR2Form 8-K - Current report
22.11.202322:39EDGAR2Form SC 13D - General statement of acquisition of beneficial..
22.11.202322:38EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15.11.202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
SELB
Selecta Biosciences
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten